Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Neonc Technologies, Inc.
Amgen
Var2 Pharmaceuticals
LigaChem Biosciences, Inc.
Telix Pharmaceuticals (Innovations) Pty Limited
Bayer
Shandong Cancer Hospital and Institute
NGM Biopharmaceuticals, Inc
Vanderbilt-Ingram Cancer Center
Prelude Therapeutics
Eastern Cooperative Oncology Group
Roswell Park Cancer Institute
Celgene
University College, London
Wake Forest University Health Sciences
AbbVie
Canadian Cancer Trials Group
Celldex Therapeutics
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Medical University of South Carolina
AbbVie
SWOG Cancer Research Network
Dana-Farber Cancer Institute
University of Miami
University of Miami
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Cancer Trials Ireland
National Cancer Institute (NCI)
National Cancer Institute (NCI)
INSYS Therapeutics Inc
National Cancer Institute (NCI)
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
East and North Hertfordshire NHS Trust
National Cancer Institute (NCI)
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
Daiichi Sankyo
National Institutes of Health Clinical Center (CC)